…they will do to lower drug prices? Why doesn’t Medicare, the biggest purchaser of drugs, directly negotiate on drug prices? What’s the deal with rebates and discounts? What is the…
Expert Commentary
…following federal policy changes, detailed in a recent study by the nonprofit Center for Connected Health Policy, are in place at least for the duration of the coronavirus pandemic and…
Expert Commentary
…‘war on drugs’ policy and rhetoric that had dominated US drug policy for decades,” write Hansen and Julie Netherland in the 2017 study “White Opioids: Pharmaceutical Race and the War…
Expert Commentary
…program to expedite the availability of new drugs that address an otherwise unmet medical need. This allows the FDA to approve drugs quickly by relying on a surrogate endpoint, which…
Expert Commentary
…at deterring gun violence. Our findings also suggest that prior city [gun buyback programs] have been poorly designed to achieve their policy objectives.” Key context The general idea behind gun…
Expert Commentary
…basic terminology, The Journalist’s Resource teamed up with two reporters with lots of experience writing about firearms. We thank Henry Pierson Curtis, who covered gun and drug trafficking and other…
Expert Commentary
…contents of food, cosmetics and drugs and barring companies from making false claims about drugs. If the Food and Drug Administration had enforced the law, it would have labelled oxycodone…
Expert Commentary
…oxycodone and fentanyl, and stimulants used to treat attention deficit disorder, like Adderall and Ritalin. Schedule III drugs include testosterone and ketamine, a former club drug that has become a…
Expert Commentary
…commonly used illegal drug among people aged 12 years and older, according to the SAMHSA’s 2019 national survey on drug use and health. It is the third most commonly used addictive drug,…
Expert Commentary
…what matters most if they get sick (cost-sharing, networks) vs healthy (gym membership) — Tricia Neuman (@tricia_neuman) October 2, 2020 For on the cost of drugs, see Drug Prices: Why…
Expert Commentary